Knight Therapeutics Inc.

Knight Therapeutics Inc.verified

KHTRF

Price:

$4.04

Market Cap:

$569.08M

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. It offers Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib to treat metastatic cholangiocarcinoma; Trelstar for advanced prostate cancer and for pain associated with endometriosis; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic adenocarcinoma; Halaven for metastatic breast cancer and doft tissue sarcoma; and Lenvima for ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2014-04-03

Stock Exchange

PNK

Ticker

KHTRF

The Enterprise Value as of November 2024 (TTM) for Knight Therapeutics Inc. (KHTRF) is 566.38M

According to Knight Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 566.38M. This represents a change of 6.56% compared to the average of 531.49M of the last 4 quarters.

Knight Therapeutics Inc. (KHTRF) Historical Enterprise Value (quarterly & annually)

How has KHTRF Enterprise Value performed in the past?

The mean historical Enterprise Value of Knight Therapeutics Inc. over the last ten years is 619.53M. The current 566.38M Enterprise Value has changed 9.04% with respect to the historical average. Over the past ten years (40 quarters), KHTRF's Enterprise Value was at its highest in in the June 2017 quarter at 943.26M. The Enterprise Value was at its lowest in in the September 2014 quarter at 248.22M.

Quarterly (TTM)
Annual

Average

619.53M

Median

603.40M

Minimum

106.82M

Maximum

955.57M

Knight Therapeutics Inc. (KHTRF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Knight Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 358.79%

Maximum Annual Enterprise Value = 955.57M

Minimum Annual Increase = -10681779690.52%

Minimum Annual Enterprise Value = 106.82M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023562.36M-5.84%
2022597.22M-2.03%
2021609.58M14.45%
2020532.63M-44.26%
2019955.57M10.07%
2018868.12M23.43%
2017703.32M-8.61%
2016769.60M57.04%
2015490.06M358.79%
2014106.82M-10681779690.52%

Knight Therapeutics Inc. (KHTRF) Average Enterprise Value

How has KHTRF Enterprise Value performed in the past?

The current Enterprise Value of Knight Therapeutics Inc. (KHTRF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

589.72M

5-year avg

651.47M

10-year avg

619.53M

Knight Therapeutics Inc. (KHTRF) Enterprise Value vs. Peers

How is KHTRF’s Enterprise Value compared to its peers?

Knight Therapeutics Inc.’s Enterprise Value is greater than Crescita Therapeutics Inc. (4.04M), greater than Cipher Pharmaceuticals Inc. (232.01M), greater than Cannara Biotech Inc. (110.40M), greater than Lowell Farms Inc. (18.42M), greater than Aion Therapeutic Inc. (5.02M), greater than HLS Therapeutics Inc. (130.03M), greater than Canntab Therapeutics Limited (1.35M), greater than Bionoid Pharma Inc. (12.34M), greater than CENTR Brands Corp. (3.48M), less than RAMM Pharma Corp. (0), less than Craftport Cannabis Corp. (9.04B), greater than Speakeasy Cannabis Club Ltd. (1.75M), greater than City View Green Holdings Inc. (4.10M), greater than RavenQuest BioMed Inc. (13.57M),

Build a custom stock screener for Knight Therapeutics Inc. (KHTRF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Knight Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Knight Therapeutics Inc. (KHTRF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Knight Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Knight Therapeutics Inc.'s Enterprise Value?

What is the highest Enterprise Value for Knight Therapeutics Inc. (KHTRF)?

What is the 3-year average Enterprise Value for Knight Therapeutics Inc. (KHTRF)?

What is the 5-year average Enterprise Value for Knight Therapeutics Inc. (KHTRF)?

How does the current Enterprise Value for Knight Therapeutics Inc. (KHTRF) compare to its historical average?